PKPD modelling to predict altered disposition of 1α,25‐dihydroxyvitamin D3 in mice due to dose‐dependent regulation of CYP27B1 on synthesis and CYP24A1 on degradation

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|14|3611-3626

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.14, 2015-07, pp. : 3611-3626

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

1α,24R‐Dihydroxyvitamin D3 Has an Ability Comparable to That of 1α,25‐Dihydroxyvitamin D3 to Induce Keratinocyte Differentiation

By  

THE JOURNAL OF DERMATOLOGY, Vol. 17, Iss. 11, 1990-11 ,pp. : 707-709

John Wiley & Sons Inc

Access to resources Recommend Favorite

1α,25-Dihydroxyvitamin D3 prevents the differentiation of human lung fibroblasts via microRNA-27b targeting the vitamin D receptor

By          

International Journal of Molecular Medicine, Vol. 36, Iss. 4, 2015-01 ,pp. : 967-974

Spandidos Publications

Access to resources Recommend Favorite

Pharmacokinetics of 1α,25-Dihydroxyvitamin D3 in Normal Mice after Systemic Exposure to Effective and Safe Antitumor Doses

By  

Oncology, Vol. 66, Iss. 1, 2004-03 ,pp. : 62-66

Karger

Access to resources Recommend Favorite

Treatment of Psoriasis Vulgaris with Oral 1α,25‐Dihydroxyvitamin D3

By  

THE JOURNAL OF DERMATOLOGY, Vol. 14, Iss. 1, 1987-02 ,pp. : 59-62

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulation of Cytokine Production in Human Peripheral Blood Mononuclear Cells and Allergen-Specific Th Cell Clones by 1α,25-Dihydroxyvitamin D3

By  

International Archives of Allergy and Immunology, Vol. 128, Iss. 1, 2002-05 ,pp. : 33-41

Karger

Access to resources Recommend Favorite